• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期 B 细胞发育和 B 细胞成熟在活动期噬血细胞性淋巴组织细胞增生症患者中受损。

Early B-cell development and B-cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis.

机构信息

Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.

Department of Pathology, Children's Healthcare of Atlanta, Atlanta, GA.

出版信息

Blood. 2023 Dec 7;142(23):1972-1984. doi: 10.1182/blood.2023020426.

DOI:10.1182/blood.2023020426
PMID:37624902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10731577/
Abstract

Hemophagocytic lymphohistiocytosis (HLH) is characterized by hyperinflammation and multiorgan dysfunction. Infections, including the reactivation of viruses, contribute to significant disease mortality in HLH. Although T-cell and natural killer cell-driven immune activation and dysregulation are well described, limited data exist on the status of B-cell compartment and humoral immune function in HLH. We noted marked suppression of early B-cell development in patients with active HLH. In vitro B-cell differentiation studies after exposure to HLH-defining cytokines, such as interferon gamma (IFN-γ) and tumor necrosis factor, recapitulated B-cell development arrest. Messenger RNA sequencing of human CD34+ cells exposed to IFN-γ demonstrated changes in genes and pathways affecting B-cell development and maturation. In addition, patients with active HLH exhibited a marked decrease in class-switched memory B (CSMB) cells and a decrease in bone marrow plasmablast/plasma cell compartments. The decrease in CSMB cells was associated with a decrease in circulating T follicular helper (cTfh) cells. Finally, lymph node and spleen evaluation in a patient with HLH revealed absent germinal center formation and hemophagocytosis with associated lymphopenia. Reassuringly, the frequency of CSMB and cTfh improved with the control of T-cell activation. Taken together, in patients with active HLH, these changes in B cells may affect the humoral immune response; however, further immune studies are needed to determine its clinical significance.

摘要

噬血细胞性淋巴组织细胞增生症(HLH)的特征是炎症过度活跃和多器官功能障碍。感染,包括病毒的再激活,导致 HLH 的死亡率显著升高。虽然 T 细胞和自然杀伤细胞驱动的免疫激活和失调得到了很好的描述,但关于 HLH 中 B 细胞区室和体液免疫功能的状态的数据有限。我们注意到活跃的 HLH 患者的早期 B 细胞发育受到明显抑制。在暴露于 HLH 定义性细胞因子(如干扰素γ(IFN-γ)和肿瘤坏死因子)后进行体外 B 细胞分化研究,重现了 B 细胞发育停滞。人类 CD34+细胞暴露于 IFN-γ的信使 RNA 测序显示,影响 B 细胞发育和成熟的基因和途径发生变化。此外,活跃的 HLH 患者表现出明显的类别转换记忆 B(CSMB)细胞减少和骨髓浆母细胞/浆细胞区室减少。CSMB 细胞的减少与循环滤泡辅助 T(cTfh)细胞的减少有关。最后,对 HLH 患者的淋巴结和脾脏进行评估,发现没有生发中心形成和吞噬作用,并伴有淋巴细胞减少。令人欣慰的是,随着 T 细胞激活的控制,CSMB 和 cTfh 的频率得到改善。总之,在活跃的 HLH 患者中,这些 B 细胞的变化可能会影响体液免疫反应;然而,需要进一步的免疫研究来确定其临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0edb/10731577/d3f1a4934317/BLOOD_BLD-2023-020426-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0edb/10731577/d3f1a4934317/BLOOD_BLD-2023-020426-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0edb/10731577/d3f1a4934317/BLOOD_BLD-2023-020426-ga1.jpg

相似文献

1
Early B-cell development and B-cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis.早期 B 细胞发育和 B 细胞成熟在活动期噬血细胞性淋巴组织细胞增生症患者中受损。
Blood. 2023 Dec 7;142(23):1972-1984. doi: 10.1182/blood.2023020426.
2
Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.BALB/c小鼠的鼠巨细胞病毒感染类似于病毒相关的继发性噬血细胞性淋巴组织细胞增生症,并显示出与原发性噬血细胞性淋巴组织细胞增生症不同的发病机制。
J Immunol. 2016 Apr 1;196(7):3124-34. doi: 10.4049/jimmunol.1501035. Epub 2016 Feb 22.
3
Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.单细胞转录组分析 Epstein-Barr 病毒相关性噬血细胞性淋巴组织细胞增生症。
J Clin Immunol. 2024 Apr 20;44(4):103. doi: 10.1007/s10875-024-01701-0.
4
IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.吲哚胺 2,3-双加氧酶 1 缺陷不影响全身型幼年特发性关节炎和继发性噬血细胞性淋巴组织细胞增生症小鼠模型中的疾病。
PLoS One. 2016 Feb 25;11(2):e0150075. doi: 10.1371/journal.pone.0150075. eCollection 2016.
5
Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.全身型幼年特发性关节炎和噬血细胞性淋巴组织细胞增生症中的细胞因子:白细胞介素-18 和干扰素-γ之间的平衡倾斜。
Rheumatology (Oxford). 2015 Aug;54(8):1507-17. doi: 10.1093/rheumatology/keu524. Epub 2015 Mar 12.
6
Hemophagoctic lymphohistiocytosis--recent concept.噬血细胞性淋巴组织细胞增生症——最新概念
J Assoc Physicians India. 2008 Jun;56:453-7.
7
Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH).区分儿童多系统炎症综合征(MIS-C)与噬血细胞性淋巴组织细胞增生症(HLH)的免疫激活和炎症特征。
J Allergy Clin Immunol. 2022 May;149(5):1592-1606.e16. doi: 10.1016/j.jaci.2022.02.028. Epub 2022 Mar 15.
8
Evaluation of lymphocyte function by IFN-γ secretion capability assay in the diagnosis of lymphoma-associated hemophagocytic syndrome.通过 IFN-γ 分泌能力检测评估淋巴瘤相关噬血细胞综合征的淋巴细胞功能。
Hum Immunol. 2019 Dec;80(12):1006-1011. doi: 10.1016/j.humimm.2019.09.003. Epub 2019 Sep 17.
9
Hemophagocytic lymphohistiocytosis: A disorder of T cell activation, immune regulation, and distinctive immunopathology.噬血细胞性淋巴组织细胞增生症:一种 T 细胞激活、免疫调节和独特免疫病理学紊乱的疾病。
Immunol Rev. 2024 Mar;322(1):339-350. doi: 10.1111/imr.13298. Epub 2023 Dec 15.
10
Natural Killer Cell Function Tests by Flowcytometry-Based Cytotoxicity and IFN-γ Production for the Diagnosis of Adult Hemophagocytic Lymphohistiocytosis.流式细胞术细胞毒性和 IFN-γ 产生检测用于成人噬血细胞性淋巴组织细胞增生症的诊断。
Int J Mol Sci. 2019 Oct 30;20(21):5413. doi: 10.3390/ijms20215413.

引用本文的文献

1
Clinical and genetic features of UNC13D deficiency with hypogammaglobulinemia.伴有低丙种球蛋白血症的UNC13D缺乏症的临床和遗传特征
Front Immunol. 2025 Aug 18;16:1628507. doi: 10.3389/fimmu.2025.1628507. eCollection 2025.
2
C3 as a predictive and prognostic biomarker in adult hemophagocytic lymphohistiocytosis: a large cohort study in China.C3作为成人噬血细胞性淋巴组织细胞增生症的预测和预后生物标志物:中国一项大型队列研究
Blood Adv. 2025 Apr 22;9(8):1836-1846. doi: 10.1182/bloodadvances.2024014715.
3
Plasma Cell Neoplasms with Spreading in the Blood and Tissues: Extramedullary Myeloma Disease, a Rare Aggressive Form of Multiple Myeloma (First of Two Parts).

本文引用的文献

1
Efficacy and safety of emapalumab in macrophage activation syndrome.埃马鲁单抗治疗巨噬细胞活化综合征的疗效和安全性。
Ann Rheum Dis. 2023 Jun;82(6):857-865. doi: 10.1136/ard-2022-223739. Epub 2023 Mar 31.
2
Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH).区分儿童多系统炎症综合征(MIS-C)与噬血细胞性淋巴组织细胞增生症(HLH)的免疫激活和炎症特征。
J Allergy Clin Immunol. 2022 May;149(5):1592-1606.e16. doi: 10.1016/j.jaci.2022.02.028. Epub 2022 Mar 15.
3
T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome.
血液和组织中播散的浆细胞肿瘤:髓外骨髓瘤,一种罕见的侵袭性多发性骨髓瘤(两部分中的第一部分)
Mediterr J Hematol Infect Dis. 2025 Jan 1;17(1):e2025005. doi: 10.4084/MJHID.2025.005. eCollection 2025.
4
Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect.患有 SNARE 蛋白 SYNTAXIN-11 缺乏症的患者和老鼠存在次级 B 细胞缺陷。
J Exp Med. 2024 Jul 1;221(7). doi: 10.1084/jem.20221122. Epub 2024 May 9.
5
Comprehensive evaluation of immune dysregulation in secondary hemophagocytic lymphohistiocytosis.继发性噬血细胞性淋巴组织细胞增生症免疫失调的综合评估。
Virulence. 2024 Dec;15(1):2342276. doi: 10.1080/21505594.2024.2342276. Epub 2024 Apr 17.
T 滤泡辅助细胞扩增和慢性 T 细胞激活是 Evans 综合征的特征性免疫异常。
Blood. 2022 Jan 20;139(3):369-383. doi: 10.1182/blood.2021012924.
4
Germline SAMD9L truncation variants trigger global translational repression.胚系 SAMD9L 截断变异可引发全局翻译抑制。
J Exp Med. 2021 May 3;218(5). doi: 10.1084/jem.20201195.
5
Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.使用 JAK 抑制剂芦可替尼治疗噬血细胞性淋巴组织细胞增生症。
Front Immunol. 2021 Feb 16;12:614704. doi: 10.3389/fimmu.2021.614704. eCollection 2021.
6
JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis.JAK抑制剂与类风湿关节炎中B细胞免疫反应的调节
Front Med (Lausanne). 2021 Feb 5;7:607725. doi: 10.3389/fmed.2020.607725. eCollection 2020.
7
Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemic.描述 2013-2016 年西非埃博拉疫情幸存者对埃博拉病毒糖蛋白的 T 细胞反应。
Nat Commun. 2021 Feb 19;12(1):1153. doi: 10.1038/s41467-021-21411-0.
8
Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature.用emapalumab成功治疗新诊断的成人斯蒂尔病患者的继发性巨噬细胞活化综合征:病例报告及文献复习
Ann Transl Med. 2020 Jul;8(14):887. doi: 10.21037/atm-20-3127.
9
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis.埃马珠单抗治疗原发性噬血细胞性淋巴组织细胞增生症患儿。
N Engl J Med. 2020 May 7;382(19):1811-1822. doi: 10.1056/NEJMoa1911326.
10
Translating IL-6 biology into effective treatments.将 IL-6 生物学转化为有效治疗方法。
Nat Rev Rheumatol. 2020 Jun;16(6):335-345. doi: 10.1038/s41584-020-0419-z. Epub 2020 Apr 23.